Added to YB: 2025-03-28
Pitch date: 2025-02-09
BHC [bearish]
Bausch Health Companies Inc.
-7.78%
current return
Author Info
No bio for this author
Company Info
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally.
Market Cap
$2.6B
Pitch Price
$6.43
Price Target
N/A
Dividend
N/A
EV/EBITDA
7.35
P/E
26.95
EV/Sales
2.39
Sector
Pharmaceuticals
Category
turnaround
Bausch Health Companies Inc. - $BHC
BHC short: Failed BLCO sale eliminates value transfer to equity. Unsustainable leverage (6.2x Net Debt/EBITDA) with $15.3B debt. EBITDA to drop ~40% in 2028 on Xifaxan loss. 2027 $4.1B maturities unmanageable. Restructuring likely by 2027, leaving minimal equity value. Near-term catalysts: 2025 maturities, going concern language.
Read full article (8 min)